Assessing and Managing Migraine
0.50 AMA PRA Category 1 Credits™
Learning Objective
Describe how to assess the patient’s quality of life between and during migraine headaches.
List the indications for starting a patient on therapy to prevent migraine headaches, and the factors in deciding when it is safe to discontinue preventive medication.
Accreditation
This educational program is conceived and credited in accordance with ACCME's Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute's Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.
| Credits |
Type |
Accreditation Statement |
Designation Statement |
| 0.50 |
AMA PRA Category 1 Credits™ |
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
Pri-Med Institute designates this educational activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
Faculty and Editorial Board
Written By:
Mark W. Green , MD, Director of Headache and Pain Medicine, Professor of Neurology, The Mount Sinai School of Medicine, New York, NY
Edited By:
Zachary Schwartz, MSc, ELS, Pri-Med Institute
Financial Disclosure Statement(s)
Dr Green serves on the speakers’ bureau for GlaxoSmithKline.
Mr Schwartz has no financial relationships to disclose.
Commercial Support:
GlaxoSmithKline, Endo Pharmaceuticals
